Donepezil Hydrochloride

ANDA 90425, held by Chartwell Rx. Donepezil Hydrochloride.

As of Nov 15, 2026, ANDA 90425 (Donepezil Hydrochloride), held by Chartwell Rx, was first approved by FDA on May 31, 2011, with 2 approved supplements and 0 published complete response letters.

First approved: May 31, 2011
Supplements approved: 2
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 3 submissions below

Date	Submission	Status	Documents
May 31, 2011	Original application	Approved	None posted

Products

2 strengths and forms


Donepezil Hydrochloride5MG · tablet;oral	Donepezil Hydrochloride	Rx
Donepezil Hydrochloride10MG · tablet;oral	Donepezil Hydrochloride	Rx

All 3 submissions, including labeling and manufacturing supplements


Nov 3, 2014	Supplement 3Labeling · Standard review	Approved	None posted
Jun 27, 2013	Supplement 2Labeling · Standard review	Approved	None posted
May 31, 2011	Original application	Approved	None posted

Identifiers

Application: ANDA 90425
Drugs@FDA: Overview at FDA
Company: Chartwell RX

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters